Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Erik Benjamin Oleson

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Denver Campus
DepartmentCLAS-Psychology

    Collapse Research 
    Collapse research activities and funding
    R03DA038734     (OLESON, ERIK BENJAMIN)Jul 1, 2015 - Jun 30, 2017
    NIH
    Potential Role of Phasic Dopamine and Endocannabinoids in Conditioned Withdrawal
    Role: Principal Investigator

    F32DA032266     (OLESON, ERIK BENJAMIN)Aug 10, 2011 - Aug 9, 2013
    NIH
    Neurobiological study on the effects of marijuana in a unique model
    Role: Principal Investigator

    F31DA024525     (OLESON, ERIK BENJAMIN)Jan 2, 2008 - Jan 1, 2011
    NIH
    Neurobiological Study of the Reinforcing Efficacy of Cocaine in Unique Models
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Behler AC, George N, Collibee C, Hamilton L, Oleson EB, Thamotharan S. A conceptual framework for queer, black womxn sexual assault survivors: an adaptation of the minoritised stress model. Cult Health Sex. 2023 06; 25(6):791-802. PMID: 35900895.
      View in: PubMed
    2. Oleson EB, Hamilton LR, Gomez DM. Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention. Front Synaptic Neurosci. 2021; 13:660218. PMID: 34177546.
      View in: PubMed
    3. Oleson EB, Khokhar JY. Cannabinoids: Emerging developments in neuropsychopharmacology and biological psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 2021 08 30; 110:110305. PMID: 33737216.
      View in: PubMed
    4. Peters KZ, Oleson EB, Cheer JF. A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking and Addiction. Cold Spring Harb Perspect Med. 2021 01 04; 11(1). PMID: 31964646.
      View in: PubMed
    5. Gomez DM, Everett TJ, Hamilton LR, Ranganath A, Cheer JF, Oleson EB. Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats. Neuropharmacology. 2021 01; 182:108374. PMID: 33115642.
      View in: PubMed
    6. Isaacs DP, Leman RP, Everett TJ, Lopez-Beltran H, Hamilton LR, Oleson EB. Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin-evoked dopamine release in rats. Neuropsychopharmacol Rep. 2020 12; 40(4):355-364. PMID: 32935483.
      View in: PubMed
    7. Everett TJ, Gomez DM, Hamilton LR, Oleson EB. Endocannabinoid modulation of dopamine release during reward seeking, interval timing, and avoidance. Prog Neuropsychopharmacol Biol Psychiatry. 2021 01 10; 104:110031. PMID: 32663486.
      View in: PubMed
    8. Oleson EB, Roberts JB. The power of price compels you: Behavioral economic insights into dopamine-based valuation of rewarding and aversively motivated behavior. Brain Res. 2019 06 15; 1713:32-41. PMID: 30543771.
      View in: PubMed
    9. Hake HS, Davis JKP, Wood RR, Tanner MK, Loetz EC, Sanchez A, Ostrovskyy M, Oleson EB, Grigsby J, Doblin R, Greenwood BN. 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats. Physiol Behav. 2019 02 01; 199:343-350. PMID: 30529341.
      View in: PubMed
    10. Brodnik ZD, Batra A, Oleson EB, Espa?a RA. Local GABAA Receptor-Mediated Suppression of Dopamine Release within the Nucleus Accumbens. ACS Chem Neurosci. 2019 04 17; 10(4):1978-1985. PMID: 30253088.
      View in: PubMed
    11. Pultorak KJ, Schelp SA, Isaacs DP, Krzystyniak G, Oleson EB. A Transient Dopamine Signal Represents Avoidance Value and Causally Influences the Demand to Avoid. eNeuro. 2018 Mar-Apr; 5(2). PMID: 29766047.
      View in: PubMed
    12. Wenzel JM, Oleson EB, Gove WN, Cole AB, Gyawali U, Dantrassy HM, Bluett RJ, Dryanovski DI, Stuber GD, Deisseroth K, Mathur BN, Patel S, Lupica CR, Cheer JF. Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain. Curr Biol. 2018 05 07; 28(9):1392-1404.e5. PMID: 29681476.
      View in: PubMed
    13. Schelp SA, Pultorak KJ, Rakowski DR, Gomez DM, Krzystyniak G, Das R, Oleson EB. A transient dopamine signal encodes subjective value and causally influences demand in an economic context. Proc Natl Acad Sci U S A. 2017 12 26; 114(52):E11303-E11312. PMID: 29109253.
      View in: PubMed
    14. Schelp SA, Brodnik ZD, Rakowski DR, Pultorak KJ, Sambells AT, Espa?a RA, Oleson EB. Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens. J Pharmacol Exp Ther. 2018 01; 364(1):145-155. PMID: 29054857.
      View in: PubMed
    15. Budygin EA, Oleson EB, Lee YB, Blume LC, Bruno MJ, Howlett AC, Thompson AC, Bass CE. Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity. Front Behav Neurosci. 2016; 10:248. PMID: 28154530.
      View in: PubMed
    16. Blanchard G, Oleson E, Fitzgerald M, Gurwitz JH. Formative Clinical Geriatrics Experiences for First- and Second-Year Medical Students: An Elusive Goal. J Am Geriatr Soc. 2015 Nov; 63(11):2438-40. PMID: 26603081.
      View in: PubMed
    17. Wenzel JM, Rauscher NA, Cheer JF, Oleson EB. A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature. ACS Chem Neurosci. 2015 Jan 21; 6(1):16-26. PMID: 25491156.
      View in: PubMed
    18. Oleson EB, Cachope R, Fitoussi A, Tsutsui K, Wu S, Gallegos JA, Cheer JF. Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. Neuropsychopharmacology. 2014 May; 39(6):1441-52. PMID: 24345819.
      View in: PubMed
    19. Hernandez G, Oleson EB, Gentry RN, Abbas Z, Bernstein DL, Arvanitogiannis A, Cheer JF. Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates. Biol Psychiatry. 2014 Mar 15; 75(6):487-98. PMID: 24138924.
      View in: PubMed
    20. Oleson EB, Cachope R, Fitoussi A, Cheer JF. Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 03; 52:17-23. PMID: 23911441.
      View in: PubMed
    21. Oleson EB, Cheer JF. On the role of subsecond dopamine release in conditioned avoidance. Front Neurosci. 2013; 7:96. PMID: 23759871.
      View in: PubMed
    22. Wang B, You ZB, Oleson EB, Cheer JF, Myal S, Wise RA. Conditioned contribution of peripheral cocaine actions to cocaine reward and cocaine-seeking. Neuropsychopharmacology. 2013 Aug; 38(9):1763-9. PMID: 23535778.
      View in: PubMed
    23. Oleson EB, Gentry RN, Chioma VC, Cheer JF. Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance. J Neurosci. 2012 Oct 17; 32(42):14804-8. PMID: 23077064.
      View in: PubMed
    24. Loewinger GC, Oleson EB, Cheer JF. Using dopamine research to generate rational cannabinoid drug policy. Drug Test Anal. 2013 Jan; 5(1):22-6. PMID: 22991092.
      View in: PubMed
    25. Oleson EB, Cheer JF. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012 Aug 01; 2(8). PMID: 22908200.
      View in: PubMed
    26. Lee AM, Oleson EB, Diergaarde L, Cheer JF, Pattij T. Cannabinoids and value-based decision making: implications for neurodegenerative disorders. Basal Ganglia. 2012 Sep 01; 2(3):131-138. PMID: 23162787.
      View in: PubMed
    27. Oleson EB, Cheer JF. Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues. Synapse. 2012 Nov; 66(11):984-8. PMID: 22807176.
      View in: PubMed
    28. Zimmer BA, Oleson EB, Roberts DC. The motivation to self-administer is increased after a history of spiking brain levels of cocaine. Neuropsychopharmacology. 2012 Jul; 37(8):1901-10. PMID: 22453139.
      View in: PubMed
    29. Oleson EB, Ferris MJ, Espa?a RA, Harp J, Jones SR. Effects of the histamine H1 receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward. Eur J Pharmacol. 2012 May 15; 683(1-3):161-5. PMID: 22445882.
      View in: PubMed
    30. Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron. 2012 Jan 26; 73(2):360-73. PMID: 22284189.
      View in: PubMed
    31. Oleson EB, Roberts DC. Cocaine self-administration in rats: threshold procedures. Methods Mol Biol. 2012; 829:303-19. PMID: 22231823.
      View in: PubMed
    32. Oleson EB, Richardson JM, Roberts DC. A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid. Psychopharmacology (Berl). 2011 Mar; 214(2):567-77. PMID: 21110008.
      View in: PubMed
    33. Espa?a RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci. 2010 Jan; 31(2):336-48. PMID: 20039943.
      View in: PubMed
    34. Oleson EB, Salek J, Bonin KD, Jones SR, Budygin EA. Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice. Neurosci Lett. 2009 Dec 25; 467(2):144-6. PMID: 19822192.
      View in: PubMed
    35. Oleson EB, Roberts DC. Behavioral economic assessment of price and cocaine consumption following self-administration histories that produce escalation of either final ratios or intake. Neuropsychopharmacology. 2009 Feb; 34(3):796-804. PMID: 18971927.
      View in: PubMed
    36. Oleson EB, Talluri S, Childers SR, Smith JE, Roberts DC, Bonin KD, Budygin EA. Dopamine uptake changes associated with cocaine self-administration. Neuropsychopharmacology. 2009 Apr; 34(5):1174-84. PMID: 18923398.
      View in: PubMed
    37. Morgan D, Liu Y, Oleson EB, Roberts DC. Cocaine self-administration on a hold-down schedule of reinforcement in rats. Psychopharmacology (Berl). 2009 Jan; 201(4):601-9. PMID: 18797847.
      View in: PubMed
    38. Oleson EB, Roberts DC. Parsing the Addiction Phenomenon: Self-Administration Procedures Modeling Enhanced Motivation for Drug and Escalation of Drug Intake. Drug Discov Today Dis Models. 2008; 5(4):217-226. PMID: 20216935.
      View in: PubMed
    39. Budygin EA, Oleson EB, Mathews TA, L?ck AK, Diaz MR, McCool BA, Jones SR. Effects of chronic alcohol exposure on dopamine uptake in rat nucleus accumbens and caudate putamen. Psychopharmacology (Berl). 2007 Sep; 193(4):495-501. PMID: 17492432.
      View in: PubMed
    40. Szumlinski KK, Abernathy KE, Oleson EB, Klugmann M, Lominac KD, He DY, Ron D, During M, Kalivas PW. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology. 2006 Apr; 31(4):768-77. PMID: 16160706.
      View in: PubMed
    41. Lominac KD, Oleson EB, Pava M, Klugmann M, Schwarz MK, Seeburg PH, During MJ, Worley PF, Kalivas PW, Szumlinski KK. Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci. 2005 Dec 14; 25(50):11586-94. PMID: 16354916.
      View in: PubMed
    42. Szumlinski KK, Lominac KD, Oleson EB, Walker JK, Mason A, Dehoff MH, Klugmann M, Klugman M, Cagle S, Welt K, During M, Worley PF, Middaugh LD, Kalivas PW. Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci. 2005 Jul 27; 25(30):7054-61. PMID: 16049182.
      View in: PubMed
    43. Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK, Schwartz MK, Seeburg PH, Seeberg PH, Worley PF, Kalivas PW. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav. 2005 Jul; 4(5):273-88. PMID: 16011574.
      View in: PubMed
    Oleson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)